Loading clinical trials…
Loading clinical trials…
Clinical trials · failure tracking
Oncology studies whose overall status is TERMINATED, WITHDRAWN or SUSPENDED on ClinicalTrials.gov, with the stop reason exactly as the registrant posted it. A category is attached only when an explicit keyword rule matches the text; CancerIndex never infers why a study stopped.
820 stopped studies mapped to Malignant Colorectal Neoplasm and descendants · 90% state a reason
Over the 820 studies matching the cancer, status and year filters (the category filter does not change this chart). Each study is counted once, in the first matching category; greyed bars are studies whose text matched no rule or was empty.
Computedrules ci-stop-reasons-v1 · keyword matching only
A category is assigned when one of its keywords appears in the posted text (case-insensitive, whole words). Rules are tested in this order and the first match wins; every match is kept in the API (reasonMatches).
| NCT | Title | Phase | Status | First posted | Lead sponsor | Why stopped (as posted) | Category |
|---|---|---|---|---|---|---|---|
| NCT03222089 | Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC | Phase 2 | withdrawn | Jul 19, 2017 | Fujian Cancer Hospital | Another study enrolling the similar group of patient are ongoing | Enrollment / accrual |
| NCT01919541 | Mechanistic Prehabilitation | N/A | withdrawn | Aug 9, 2013 | Franco Carli | difficulty in recruiting patients | Enrollment / accrual |
| NCT01284504 | Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer | N/A | terminated | Jan 27, 2011 | Stanford University | low accrual rate; the only participant withdrew after signing consent | Enrollment / accrual |
| NCT03307603 | Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From… | Phase 1 / Phase 2 | withdrawn | Oct 11, 2017 | Case Comprehensive Cancer Center | Sponsor chose not to continue | Other (stated, no rule matched) |
| NCT01710293 | Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in…(PACT CREATE 3) | N/A | withdrawn | Oct 19, 2012 | VA Office of Research and Development | Unable to obtain data needed to run the RCT; project never began recruitment | Enrollment / accrual |
| NCT02110953 | Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal… | Phase 1 | terminated | Apr 10, 2014 | Fox Chase Cancer Center | IRB study closure by investigator due to low enrollment | Investigator |
| NCT00388700 | A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With… | Phase 2 | withdrawn | Oct 17, 2006 | Galectin Therapeutics Inc. | Financing and re-organization | Funding |
| NCT02119676 | Study of Ruxolitinib in Colorectal Cancer Patients | Phase 2 | terminated | Apr 22, 2014 | Incyte Corporation | Substudy 1 was terminated for futility at interim analysis and Substudy 2 was terminated per… | Efficacy / futility |
| NCT01934179 | Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal… | — | terminated | Sep 4, 2013 | Fox Chase Cancer Center | Low Accrual Rate | Enrollment / accrual |
| NCT02163187 | Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for… | Phase 2 / Phase 3 | terminated | Jun 13, 2014 | Memorial Sloan Kettering Cancer Center | Study permanently closed due to low accrual | Enrollment / accrual |
| NCT02399631 | Enhanced Recovery Program After Laparoscopic Colon Cancer Surgery | N/A | terminated | Mar 26, 2015 | Kyungpook National University Hospital | not stated | Not stated |
| NCT02407561 | Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein… | — | terminated | Apr 3, 2015 | Castle Biosciences Incorporated | Futility - unable to secure sites and samples for participation | Efficacy / futility |
| NCT01729923 | A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With…(ADAPT) | Phase 2 | terminated | Nov 20, 2012 | University of Washington | Funding ended | Funding |
| NCT01012362 | Study of Pazopanib and Ixabepilone in Patients With Solid Tumors | Phase 1 | terminated | Nov 13, 2009 | Masonic Cancer Center, University of Minnesota | PI left institution. | Investigator |
| NCT02182466 | German Colon Capsule Registry(DEKOR) | — | terminated | Jul 8, 2014 | Johann Wolfgang Goethe University Hospital | not stated | Not stated |
| NCT00226941 | A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and… | Phase 1 / Phase 2 | terminated | Sep 27, 2005 | George Albert Fisher | The response rate observed in the phase 1 portion of the study did not merit further evaluation in… | Other (stated, no rule matched) |
| NCT01279681 | Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older… | Phase 3 | terminated | Jan 19, 2011 | Alliance for Clinical Trials in Oncology | Slow accrual | Enrollment / accrual |
| NCT02057991 | Mindfulness-Based Exercise Video in Educating Hispanic/Latino Patients With Colorectal… | N/A | terminated | Feb 7, 2014 | University of Southern California | Insufficient Accrual | Enrollment / accrual |
| NCT00903396 | Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy… | Phase 2 | terminated | May 18, 2009 | Alliance for Clinical Trials in Oncology | Slow accrual | Enrollment / accrual |
| NCT00625183 | Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients… | Phase 2 | terminated | Feb 28, 2008 | Roswell Park Cancer Institute | Withdrawn due to poor/low accrual | Enrollment / accrual |
| NCT01606124 | Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer | Phase 2 | terminated | May 25, 2012 | Mayo Clinic | pending expiration of the supply of study agent. | Drug supply |
| NCT02630420 | Cetuximab and Savolitinib Treatment of Ras Wild-Type Colorectal Cancer | Phase 1 | withdrawn | Dec 15, 2015 | Yale University | The study never officially funded and therefore never began. | Funding |
| NCT02774512 | Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in…(ZAK-0) | Early Phase 1 | withdrawn | May 17, 2016 | Institut Bergonié | none participant has been enrolled and recruited during the first year after competent autority… | Enrollment / accrual |
| NCT03007771 | Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild… | Phase 1 | withdrawn | Jan 2, 2017 | Washington University School of Medicine | Decision was made to not go forward with the study | Other (stated, no rule matched) |
| NCT00003485 | Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer | Phase 2 | terminated | Jan 27, 2003 | Burzynski Research Institute | slow accrual | Enrollment / accrual |
| NCT02615574 | A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With… | Phase 2 | withdrawn | Nov 26, 2015 | Pawel Kalinski | Due to inadequate supply of drug | Drug supply |
| NCT02542436 | Avastin (Bevacizumab) in the Treatment of Metastatic Colorectal Cancer in Normal Clinical… | — | withdrawn | Sep 7, 2015 | Hoffmann-La Roche | not stated | Not stated |
| NCT02538627 | Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib | Phase 1 | terminated | Sep 2, 2015 | Merrimack Pharmaceuticals | Sponsor decision | Sponsor / business decision |
| NCT02609451 | Closure of Protective Ileostomy 2 vs. 12 Weeks After TME(Closure2vs12) | N/A | terminated | Nov 20, 2015 | Kantonsspital Liestal | Evidence of bad outcome after interims analysis | Other (stated, no rule matched) |
| NCT03264274 | Trial of Aflibercept Monotherapy With DCE-US in Chemorefractory Metastatic Colorectal…(AUSCOR) | Phase 2 | withdrawn | Aug 29, 2017 | Barts & The London NHS Trust | Funding restrictions - study never opened to recruitment | Enrollment / accrual |
| NCT02345746 | Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in… | Phase 2 | withdrawn | Jan 26, 2015 | Western Regional Medical Center | patient population | Other (stated, no rule matched) |
| NCT01114256 | FNA Tumor Sampling for CD137 Modulation: A Pilot Study | — | terminated | May 3, 2010 | Stanford University | not stated | Not stated |
| NCT02079220 | A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX)… | Phase 2 | withdrawn | Mar 5, 2014 | James J Lee | Funding for the study was withdrawn, no participants were ever recruited. | Enrollment / accrual |
| NCT01847599 | Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib(ProMETheX) | N/A | terminated | May 7, 2013 | Centre Jean Perrin | interim analysis : discontinuation for efficacy of the intervention | Efficacy / futility |
| NCT00002664 | Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With… | Phase 2 | withdrawn | May 24, 2004 | James Ahlgren | No recruitment | Enrollment / accrual |
| NCT01309126 | Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or…(PRIMUS) | Phase 3 | terminated | Mar 4, 2011 | HiberCell, Inc. | Due to enrollment challenges resulting from changing treatment patterns in the use of cetuximab,… | Enrollment / accrual |
| NCT01095523 | Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS… | Phase 2 | withdrawn | Mar 30, 2010 | National Cancer Institute (NCI) | not stated | Not stated |
| NCT01176500 | A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of… | Phase 1 / Phase 2 | withdrawn | Aug 6, 2010 | National Cancer Institute (NCI) | not stated | Not stated |
| NCT01386502 | CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors | Phase 1 | withdrawn | Jul 1, 2011 | National Cancer Institute (NCI) | not stated | Not stated |
| NCT01936961 | Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid…(I-CREST) | N/A | withdrawn | Sep 6, 2013 | Western Regional Medical Center | No patients enrolled | Enrollment / accrual |
| NCT00408772 | Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency… | Phase 2 | withdrawn | Dec 7, 2006 | University of California, Davis | Lack of accrual | Enrollment / accrual |
| NCT01940237 | A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients… | N/A | terminated | Sep 12, 2013 | New York State Psychiatric Institute | Low recruitment | Enrollment / accrual |
| NCT00449163 | Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal… | Phase 2 | terminated | Mar 19, 2007 | University of Miami | Study terminated by University of Miami Institutional Review Board | Other (stated, no rule matched) |
| NCT01326065 | Implementation of Laparoscopy-assisted Surgery for Colon Cancer | — | terminated | Mar 30, 2011 | Helse Stavanger HF | Study had to be terminated due to lack of funding | Funding |
| NCT01646554 | Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With…(BOS3) | Phase 2 / Phase 3 | withdrawn | Jul 20, 2012 | European Organisation for Research and Treatment of Cancer - EORTC | not stated | Not stated |
| NCT02277093 | Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal Cancer | Phase 2 | terminated | Oct 28, 2014 | Washington University School of Medicine | FDA issued a clinical hold as pacritinib had increased side effects | Other (stated, no rule matched) |
| NCT02060669 | Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer | Phase 3 | terminated | Feb 12, 2014 | Samsung Medical Center | others | Other (stated, no rule matched) |
| NCT02413853 | Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients…(PRIMIER) | Phase 2 | withdrawn | Apr 10, 2015 | University of Southern California | Study drug supply issues | Drug supply |
| NCT00126451 | A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed… | Phase 2 | terminated | Aug 4, 2005 | Merck Sharp & Dohme LLC | not stated | Not stated |
| NCT00588900 | Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did… | Phase 2 | terminated | Jan 9, 2008 | Alliance for Clinical Trials in Oncology | not stated | Not stated |
Stop reasons are registrant-reported free text and are displayed verbatim (truncated; hover for the full text). Categories come from explicit keyword rules and are never inferred from the study design, sponsor or outcome; a study that stopped for several reasons is filed under the first rule that matched. A TERMINATED status does not imply a negative result.
Data updated 23 days agoSource updated Mar 27, 2018source: clinicaltrials